4 clinics shown
TMS therapy and psychiatric services are provided at A Better Way Psychiatry & TMS in Carlsbad, located on Palomar Airport Road near the 5 freeway. The practice specializes in treating adults with depression who have not responded adequately to medication trials. Board-certified psychiatrists oversee both TMS protocols and ongoing medication management, with treatment plans tailored to individual patient histories and symptom profiles.
BrainCare Performance Center operates a neurology and neuropsychology practice in Carlsbad on Camino De Los Coches, serving patients with cognitive and neurological concerns. The clinic provides neurological evaluations, neuropsychological testing, and performance optimization services. Specific treatment modalities such as TMS, ketamine, or esketamine are not detailed in available listings; patients should contact the practice directly to confirm whether these procedural treatments are offered. The center treats both adults and adolescents requiring neurological or cognitive assessment.
Mental health clinic in Carlsbad, California.
Sollus Health operates a psychiatric practice in Carlsbad on El Camino Real, providing mental health services for adults in North San Diego County. The clinic offers psychiatric evaluations and medication management, though specific treatment modalities such as TMS, esketamine, or ketamine therapy are not detailed in available information. Patients seeking procedural or device-based treatments should contact the practice directly to confirm current service offerings.
Spravato is the brand name for esketamine, an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. It's derived from ketamine and works on the brain's glutamate system — a different mechanism than traditional antidepressants like SSRIs.
Treatment is administered only at REMS-certified clinics under direct medical supervision. Patients self-administer the spray under a clinician's guidance, then remain at the clinic for at least two hours of monitoring after each dose. The induction phase typically involves twice-weekly sessions for four weeks, followed by weekly or biweekly maintenance dosing depending on response.
Many patients report meaningful symptom improvement within the first one to two weeks — substantially faster than the 4 to 8 weeks typical of oral antidepressants. Spravato is taken alongside an oral antidepressant, not as a replacement.
The most common side effects are dissociation, dizziness, sedation, and elevated blood pressure during and shortly after dosing. These typically resolve within the two-hour monitoring window. Patients cannot drive on the day of treatment.
Most commercial insurance and Medicare cover Spravato for treatment-resistant depression with prior authorization. Clinics offering Spravato in our directory hold active REMS certification and are staffed to provide the required in-clinic monitoring period.